Navigation Links
ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results
Date:11/2/2010

year, plus promotional activities associated with the launch of BEPREVE.

Operating income for the quarter ended September 30, 2010, was $4.8 million, compared to an operating income of $5.2 million in the corresponding quarter of 2009, which included the license revenue of $2.9 million.

Other expense for the quarters ended September 30, 2010 and 2009, included non-cash valuation losses of $26.3 million and $3.4 million, respectively, as a result of marking common stock warrants to market.  Non-cash warrant valuation adjustments are driven primarily by the change in ISTA's stock price quarter over quarter.  The non-cash warrant valuation loss decreased reported net loss for the quarter ended September 30, 2010, to $23.5 million, or $0.70 per diluted share.  Without the non-cash warrant valuation loss, net income was $2.8 million, or $0.08 per diluted share.  In the third quarter of 2009, the non-cash warrant valuation loss for the third quarter 2009 decreased reported net loss to $917,000, or $0.03 per diluted share.  Without the non-cash warrant valuation loss, third quarter 2009 net income was $2.5 million, or $0.07 per diluted share.

At September 30, 2010, ISTA had cash of $67.2 million, which included $13 million borrowed under ISTA's revolving line of credit with Silicon Valley Bank.  Cash at September 30, 2010, included $16.7 million of reserved royalties on bromfenac.

ISTA Reaffirms 2010 Net Revenues and Net Income Guidance

  • ISTA expects its net revenues for 2010 will be approximately in the middle of the $147 million to $165 million range.  ISTA expects sales from XIBROM and BROMDAY combined will be at the higher end of the $95 million to $105 million range and anticipates sales from BEPREVE will be approximately $16 million to $20 million.

  • ISTA expects its gross margin will be at the higher end of the 74% to 76% range of net revenues.

  • ISTA expects R&D expenses
    '/>"/>

  • SOURCE ISTA Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
    2. Access Pharmaceuticals Awarded $1.5 Million in Section 48D Grants
    3. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
    4. Alder Biopharmaceuticals Appoints Bruce Montgomery to Board of Directors
    5. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
    6. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
    7. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
    8. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2010 Financial Results on November 5, 2010
    9. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2010 Financial Results
    10. VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
    11. MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX™ in FREEDOM-301 Trial
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/22/2014)... -- Prostate cancer is the second leading cause of cancer ... caught early - the problem is that too often ... Conditions Education Council (PCEC), – a national organization ... cancer screening –  is sponsoring its 25 th ... Committed to encouraging men to take ...
    (Date:9/22/2014)... , Sept. 22, 2014 CytRx Corporation ... development company specializing in oncology, today announced that study ... clinical trials of aldoxorubicin, a pivotal global Phase 3 ... a global Phase 2b clinical trial in small cell ... for Medical Oncology (ESMO) 2014 Congress being held September ...
    (Date:9/19/2014)... CHAPEL HILL, N.C. , Sept. 19, 2014 ... critical role in forging relationships with key opinion ... the market and competition. Despite the critical nature ... has created many challenges, including altering the landscape ... According to research, the oversight ...
    Breaking Medicine Technology:PCEC Encourages Men Across America to Have a Baseline Prostate Health Assessment During the Annual Prostate Cancer Awareness Week 2PCEC Encourages Men Across America to Have a Baseline Prostate Health Assessment During the Annual Prostate Cancer Awareness Week 3CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 2CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 3CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 4CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 5CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 6Role of Medical Science Liaisons Shifting in Healthcare Industry 2
    ... the annual,meeting of the Pediatric Academic Societies (PAS) shows ... the start of the typical flu,vaccination season -- healthcare ... children are already in the doctor,s office.,The potential impact ... that less than 20 percent of school-aged children between ...
    ... May 5 N30 Pharma (N30), a,biopharmaceutical company ... that target endogenous s-nitrosothiols,announced today that it has ... with mild to moderate asthma, as well as ... treatment of reactive and,obstructive airway diseases, including Cystic ...
    Cached Medicine Technology:Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors' Visits 2Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors' Visits 3Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors' Visits 4N30 Pharma Announces Completion of Phase 1 Clinical Studies With N30-201 2
    (Date:9/22/2014)... 2014 The report segments the ... user, and geography. The equipment segment accounted for ... market, by product. However, the accessories segment is ... the forecast period, owing to the rising demand ... and ultrasound segments are the fastest-growing segments in ...
    (Date:9/22/2014)... participate in athletics will be asked to sign a ... ensure parents are confident about handling the injury, according ... Hospital National Poll on Children,s Health. , In the ... and high school children surveyed reported participation in some ... read a brochure or online information, 17% have ...
    (Date:9/22/2014)... and leadership of Senators Sherrod Brown (D-Ohio) and ... primary care services were lauded yesterday by the ... organizations, representing internal medicine and related subspecialties. ... for introducing the Ensuring Access to Primary Care ... will extend current-law payment rates under Medicaid for ...
    (Date:9/22/2014)... 2014) The success of a colonoscopy is closely ... often resulting in missed precancerous lesions, according to new ... on Colorectal Cancer. Additionally, poor bowel cleansing can result ... to 20 to 25 percent of all colonoscopies are ... "When prescribing bowel preparation for their patients, health-care professionals ...
    (Date:9/22/2014)... laser weapons, the Office of Naval Research (ONR) this ... Day Marine exposition that will prepare Marines as they ... ONR program officers will be in Booth No. 2305 ... Base Quantico, to discuss how their research contributes to ... austere and lethal." , ONR,s Expeditionary Maneuver Warfare and ...
    Breaking Medicine News(10 mins):Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 2Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 3Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 4Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 5Health News:Some concussion education more useful than others, parents say 2Health News:Broad physician coalition urges Congress to extend Medicaid pay parity 2Health News:Good bowel cleansing is key for high-quality colonoscopy 2Health News:Good bowel cleansing is key for high-quality colonoscopy 3Health News:Modern Day Marine: ONR features technology for marines of the future 2
    ... CREEK, Calif., March 7 Longs Drug,Stores Corporation ... J. Vasos has been,named executive vice president and ... who has left the Company. Vasos will,be responsible ... Vasos joined Longs in 2001 as senior ...
    ... available in Spanish . , Researchers from the ... the University of Granada have carried out a ... come to is that an efficient response in primary care ... caused by three of the most frequent pathologies in older ...
    ... health care to be released at forum, LOS ... MAYA:, What: MAYA along with leading business and ... Better Through Communication" to,seek new ways to promote better ... and the Latino Issues Forum will release the,findings of ...
    ... IPC The,Hospitalist Company, Inc. (Nasdaq: IPCM ), a ... hospitalist medicine services,announced today that it will report results ... 20, 2008, before the market opens., A conference ... a.m. ET,(6:00 a.m. PT) on March 20, 2008 and ...
    ... Western Reserve University School of Medicine researchers published a ... Journal of Human Genetics identifying the hereditary components of ... in a Genome-wide Scan: Results from the Colon Neoplasia ... families with CRC and colon polyps in the country. ...
    ... physical, mental scores, study finds , , FRIDAY, March 7 ... families boosts children,s physical and mental development, a U.S. ... California, Berkeley found that children in low-income families in ... a government-run conditional cash transfer program were taller, less ...
    Cached Medicine News:Health News:Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 2Health News:An efficient response in primary care would reduce the use of hospitals by elderly people 2Health News:Nationwide Telephone News Briefing for U.S. Health Disparities Forum 2Health News:IPC The Hospitalist Company, Inc. to Report Fourth Quarter and Year-End 2007 Financial Results 2Health News:Case Western Reserve University researchers identify colorectal cancer gene 2Health News:Government Assistance Linked to Better Child Development 2
    ... dedicated to the principles of excellence and ... committed to aiding the clinician in early ... design of profiles and panels that provide ... tests. These tests assist to resolve the ...
    ChildLab is a service of Children's Hospital, Columbus Ohio...
    Millenova Immunology Laboratories is a reference laboratory dedicated to the diagnosis of immunologic causes of reproductive failure, infertility and recurrent pregnancy loss....
    Marquette General Health System Reference Laboratory provides a full range of testing including, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, Cytology, Anatomic Pathology, Flow Cytom...
    Medicine Products: